Tencent owns more than 40% of the China-based live game streaming platform, which has chosen New York for its initial public offering.

Gilead Sciences, Boehringer Ingelheim and Takeda all recorded exits as immunotherapy developer Hookipa went public, floating at the bottom of its range.

Life360, backed by ADT, BMW and Duchossois Group, plans to go public in Australia next month after pricing its shares for a company valuation of $494m.

Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.

Zoom is floating above its range in an IPO in which Qualcomm will make an immediate $30.6m return, while Salesforce is buying $100m of shares through a private placement.

Outdoor electronic goods producer Sonim Technologies has filed for a $57.5m initial public offering that would provide exits for Motorola Solutions and JVC Kenwood.

Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.

Alexandria Real Estate Equities-backed molecular therapy developer Applied Therapeutics is aiming for $86.3m in its initial public offering.

Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.

The biopharmaceutical company, formerly known as Pronutria Biosciences and backed by Nestlé Health Science, has filed for an $86.3m offering following $172m of funding.